CollPlant Biotechnologies (CLGN) Net Equity Issued and Repurchased (2018 - 2021)

CollPlant Biotechnologies (CLGN) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $50000.0 in Q1 2021.

• Quarterly Net Equity Issued and Repurchased fell 98.88% year-over-year to $50000.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $50000.0 (changed N/A YoY) and the FY2021 annual result came in at $50000.0, changed N/A from the prior year.
• Net Equity Issued and Repurchased climbed to $50000.0 in Q1 2021, from -$50000.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $4.4 million in Q1 2020 to a low of -$50000.0 in Q2 2020.
• A 3-year average of $1.2 million and a median of $291000.0 in 2018 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 98.88% in 2021, down 98.88% in 2021.
• Tracing CLGN's Net Equity Issued and Repurchased over 3 years: stood at $532000.0 in 2018, then sank by 109.4% to -$50000.0 in 2020, then surged by 200.0% to $50000.0 in 2021.
• The last three Net Equity Issued and Repurchased figures came in at $50000.0 (Q1 2021), -$50000.0 (Q2 2020), and $4.4 million (Q1 2020), per Business Quant data.